- Home
- ALZN vs KITT Comparison
ALZN vs KITT Comparison
Compare ALZN & KITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- KITT
- Stock Information
- Founded
- ALZN 2016
- KITT 2014
- Country
- ALZN United States
- KITT United States
- Employees
- ALZN N/A
- KITT N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- KITT Industrial Machinery/Components
- Sector
- ALZN Health Care
- KITT Industrials
- Exchange
- ALZN Nasdaq
- KITT Nasdaq
- Market Cap
- ALZN 6.1M
- KITT 5.8M
- IPO Year
- ALZN 2021
- KITT N/A
- Fundamental
- Price
- ALZN $1.17
- KITT $2.00
- Analyst Decision
- ALZN Strong Buy
- KITT
- Analyst Count
- ALZN 1
- KITT 0
- Target Price
- ALZN $32.00
- KITT N/A
- AVG Volume (30 Days)
- ALZN 145.7K
- KITT 17.4M
- Earning Date
- ALZN 12-12-2024
- KITT 11-12-2024
- Dividend Yield
- ALZN N/A
- KITT N/A
- EPS Growth
- ALZN N/A
- KITT N/A
- EPS
- ALZN N/A
- KITT N/A
- Revenue
- ALZN N/A
- KITT $2,399,852.00
- Revenue This Year
- ALZN N/A
- KITT $980.78
- Revenue Next Year
- ALZN N/A
- KITT N/A
- P/E Ratio
- ALZN N/A
- KITT N/A
- Revenue Growth
- ALZN N/A
- KITT N/A
- 52 Week Low
- ALZN $1.06
- KITT $0.82
- 52 Week High
- ALZN $15.06
- KITT $17.14
- Technical
- Relative Strength Index (RSI)
- ALZN 45.87
- KITT 50.21
- Support Level
- ALZN $1.13
- KITT $2.01
- Resistance Level
- ALZN $1.23
- KITT $3.44
- Average True Range (ATR)
- ALZN 0.06
- KITT 0.94
- MACD
- ALZN 0.01
- KITT -0.12
- Stochastic Oscillator
- ALZN 37.20
- KITT 14.54
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About KITT Nauticus Robotics Inc.
Nauticus Robotics Inc develops autonomous robots for the ocean industries. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing of related software to both the commercial and defense business sectors. Nauticus' services provide customers with the necessary data collection, analytics, and subsea manipulation capabilities to support and maintain assets while reducing their operational footprint, operating cost, and greenhouse gas emissions, to improve offshore health, safety, and environmental exposure.